Influenza — Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
Citation(s)
Alcusky MJ, Cannon-Dang E, Steele D, Schafer JJ, DeSimone Jr JA, Pizzi LT. Cost of a pharmacist-led pneumonia education and immunization program for older Philadelphians. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20 2015 Philadelphia, PA.
Harris LM, Chin NP, Fiscella K, Humiston S Barrier to pneumococcal and influenza vaccinations in Black elderly communities: mistrust. J Natl Med Assoc. 2006 Oct;98(10):1678-84.
Hoffmann S, Caro FG, Gottlieb AS, Kesternich I, Winter JK Contributions of Second Opinions, Outcome Forecasts, and Testimonials to Patient Decisions about Knee Replacement Surgery. Med Decis Making. 2014 Jul;34(5):603-14. doi: 10.1177/0272989X14527796. Epub 2014 Apr 16.
Kennedy DT, Small RE Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):83-92.
Linnan LA, D'Angelo H, Harrington CB A literature synthesis of health promotion research in salons and barbershops. Am J Prev Med. 2014 Jul;47(1):77-85. doi: 10.1016/j.amepre.2014.02.007. Epub 2014 Apr 24. Review.
Lu PJ, Euler GL, Jumaan AO, Harpaz R Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009 Feb 5;27(6):882-7. doi: 10.1016/j.vaccine.2008.11.077. Epub 2008 Dec 9.
Luque JS, Ross L, Gwede CK Qualitative systematic review of barber-administered health education, promotion, screening and outreach programs in African-American communities. J Community Health. 2014 Feb;39(1):181-90. doi: 10.1007/s10900-013-9744-3. Review.
Mieczkowski TA, Wilson SA Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine. 2002 Jan 31;20(9-10):1383-92.
Pizzi LT, Steele D, Sembhi H, Hark L, Waisbourd M, Katz LJ Cost analysis of the Philadelphia glaucoma community detection and treatment project. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA.
Prioli K, Schafer J, Fields Harris L, McCoy M, Barber E, Marthol-Clark M, Pizzi LT Awareness and beliefs about pneumococcal and influenza vaccination among older African Americans: Results from a survey of community-dwelling participants at an urban senior center. Poster presented at: The 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 20, 2013; New Orleans, Louisiana.
Schafer JJ, Steele D, Marthol MM, Harris LF, Pizzi LT Knowledge gaps about pneumonia in older adults: results from the pharmacists' pneumonia prevention project. Poster presentation at the ISPOR 20th Annual International Meeting, May 16-20, 2015 Philadelphia, PA.
Singleton JA, Santibanez TA, Wortley PM Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences. Am J Prev Med. 2005 Dec;29(5):412-20.
Swendeman D, Ingram BL, Rotheram-Borus MJ Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care. 2009 Oct;21(10):1321-34. doi: 10.1080/09540120902803158. Review.
Ubel PA, Jepson C, Baron J The inclusion of patient testimonials in decision aids: effects on treatment choices. Med Decis Making. 2001 Jan-Feb;21(1):60-8.
Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341-9. Erratum in: Mayo Clin Proc. 2008 Feb;83(2):255.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.